The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X.
Russell
Stuart J
SJ
Di Stefano
Eugenie M
EM
Naffati
Mahmud T
MT
Brown
Oliver
O
Saltissi
Stephen
S
D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D000077405:Irbesartan; D008297:Male; D017566:Microvascular Angina / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan